Cryopreservation as a way to maintain extracorporeal photopheresis regimen for GvHD treatment while circumventing patient temporary inability to undergo apheresis
Bone Marrow Transplant
.
2017 Jan;52(1):167-170.
doi: 10.1038/bmt.2016.240.
Epub 2016 Sep 19.
Authors
C Pochon
1
,
L Reppel
2
,
P Halle
3
,
A Zang
4
,
L Clément
1
,
D Michel
1
,
A Perrot
1
,
G Roth-Guépin
1
,
M Detrait
1
,
J Kanold
3
5
,
N Rouel
5
,
B Donzé
6
,
V Décot
2
,
S Mathieu-Nafissi
6
,
E Merlin
5
,
D Bensoussan
2
Affiliations
1
Allogeneic Hematopoietic Stem Cell Transplantation Unit, Department of Hematology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
2
Department of Cell Therapy, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
3
Department of Cell Therapy, Cell Therapy Unit, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
4
Department of Paediatric Anaesthesia, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
5
Department of Paediatric Clinical Research, INSERM CIC-1405, Clermont-Ferrand, France.
6
Department of Therapeutic Hemapheresis, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
PMID:
27643864
DOI:
10.1038/bmt.2016.240
No abstract available
MeSH terms
Cryopreservation / methods*
Graft vs Host Disease / pathology
Graft vs Host Disease / therapy*
Humans
Photopheresis / methods*